publicFDA · United States · Updated Aug 17, 2026
Revised FDA Guidance on ANDA and 505(b)(2) Application Submission
Implement a gap analysis for 505(b)(2) applications to identify safety data needs and adjust safety monitoring systems as necessary to accommodate new product characteristics.
Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward